Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

117.11 +0.68 (+0.58%)
Official Closing Price Updated: 7:00 PM EDT, Sep 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Abbott Q2 Profit More Than Doubles As Medical Device Sales Rebound
Abbott Laboratories Q2 profit more than doubled to $2.1 billion due to strength in its diagnostics business and a rebound in medical device sales. 
Via Talk Markets
Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance
Quest Diagnostics Incorporated (NYSE: DGX) posted better-than-expected second-quarter results, as vaccinations and the lifting of lockdowns resulted in recovery in its... 
Via Benzinga
Abbott Labs Beats Second-Quarter Views, But Covid Testing Demand Dives
Abbott on Thursday reported adjusted earnings of $1.17 per share on $10.2 billion in second-quarter sales. But ABT stock dipped a fraction. 
Via Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
Exposures Product Safety
Abbott Q2 Profit More Than Doubles As Medical Device Sales Rebound
Abbott Laboratories (NYSE: ABT) Q2 profit more than doubled to $2.1 billion due to strength in its diagnostics business and a rebound in medical device sales. As... 
Via Benzinga
Abbott Laboratories: Q2 Earnings Insights
Shares of Abbott Laboratories (NYSE:ABT) decreased 0.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 105.26% over... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings, Economic Data
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the release of jobless claims data. The Dow Jones surged more than 280 points in the previous... 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Stocks To Watch For July 22, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects AT&T Inc. (NYSE: T) to report quarterly earnings at $0.79 per share on revenue of $42.64... 
Via Benzinga
Unusual Options Activity Insight: Abbott Laboratories
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Wednesday. The stock price moved down to $117.92 following the option alert. Sentiment: BULLISH... 
Via Benzinga
Earnings Scheduled For July 22, 2021
Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,... 
Via Benzinga
5 Hottest Earnings Charts This Week
These 5 companies are the best this week. One of them hasn’t missed in five years and is also trading near 5-year highs. 
Via Talk Markets
Analyzing Abbott Laboratories's Unusual Options Activity
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Monday. The stock price moved up to $119.12 following the option alert. Sentiment: BEARISH Option... 
Via Benzinga
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears,... 
Via Talk Markets
Exposures Product Safety
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week... 
Via Benzinga
Exposures Product Safety
5 Stocks to Own for the Surge in Coronavirus Variants
Despite easing restrictions, COVID is going to be around a lot longer than many think. 
Via The Motley Fool
Exposures COVID-19
Understanding Abbott Laboratories's Unusual Options Activity
On Tuesday, shares of Abbott Laboratories (NYSE:ABT) saw unusual options activity. After the option alert, the stock price moved down to $118.44. Sentiment: BULLISH Option Type... 
Via Benzinga
46 Firms Going Ex-Dividend, Including Oracle, Accenture And PNC Financial
There are several well-known large-cap stocks going ex-dividend this week 
Via Talk Markets
Abbott Lays Off Around 400 Employees As COVID-19 Test Demand Evaporates
Abbott Laboratories (NYSE: ABT) has begun laying off hundreds of workers at its diagnostic plants a month after it slashed its earnings forecasts for the remainder of... 
Via Benzinga
Topics Workforce
Exposures COVID-19 Layoff
Danaher Stock Rises To Fresh High; Alderon Acquisition Will Expand DNA Portfolio
Danaher stock rose June 18 after it said it's buying Aldevron, which makes DNA and mRNA, a component in Covid19 vaccines, for $9.6 billion. 
Via Investor's Business Daily
These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval
Some might be surprised to see income-paying stocks among the ARK Invest founder's high-growth picks. 
Via The Motley Fool
What Does The Fed Rate-Hike Plan Do To Dividend Investors?
The Fed forecast for two rate hikes by the end of 2023 changed the outlook for income investors. Some high-yield stocks sold off after the announcement, but there are stocks that offer a decent yield... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Where Abbott Laboratories Stands With Analysts
Analysts have provided the following ratings for Abbott Laboratories (NYSE:ABT) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 2 0... 
Via Benzinga
Understanding Abbott Laboratories's Unusual Options Activity
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Wednesday. The stock price moved up to $111.16 following the option alert. Sentiment: BULLISH... 
Via Benzinga
Return On Capital Employed Overview: Abbott Laboratories
Abbott Laboratories (NYSE:ABT) posted Q1 earnings of $2.11 billion, an increase from Q4 of 13.28%. Sales dropped to $10.46 billion, a 2.29% decrease between quarters. Abbott... 
Via Benzinga
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ: DXCM) and Abbott Laboratories (NYSE:... 
Via Benzinga
Revisiting Abbott Labs: Recent Pullback Found Support At The 52-Week Moving Average
Abbott saw its stock drop dramatically when the company lowered guidance on June 1. Even after the lowered guidance the growth rates are better than average. The stock found support at its 52-week... 
Via Talk Markets
This Underappreciated Healthcare Stock Is on Sale: Should You Buy?
Despite recent struggles, the investment thesis for this company remains strong. 
Via The Motley Fool
Exposures COVID-19
What Should Investors Make of Abbott's Reduced Full-Year Guidance?
The bad news: COVID-19 test volumes are falling. The good news: Abbott has other growth drivers. 
Via The Motley Fool
Exposures COVID-19
Understanding Abbott Laboratories's Unusual Options Activity
Shares of Abbott Laboratories (NYSE:ABT) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved up to $110.21. Sentiment: BULLISH... 
Via Benzinga
Is Abbott Laboratories a Buy on the Dip?
The business is growing in all areas, but is it enough to justify the stock's hefty valuation? 
Via The Motley Fool
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.